SOMAXON PHARMACEUTICALS, INC. Stock-Based Compensation
SOMAXON PHARMACEUTICALS, INC. reported Stock-Based Compensation of $1.95 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $584.00K, a 64.99% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $682.00K, a 51.04% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $688.00K, a 42.43% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $992.00K, a 29.75% decline year-over-year.
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2011 was $5.25M, a 21.74% decline from fiscal 2010.
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2010 was $6.71M, a 8.81% increase from fiscal 2009.
- SOMAXON PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2009 was $6.16M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $584.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $1.27M derived: sum of 2 quarters · filed 2012-11-01 | $1.95M 10-Q · filed 2012-11-01 | $2.95M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-06-30 | $682.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $1.37M 10-Q · filed 2012-08-08 | $2.36M derived: sum of 3 quarters · filed 2012-08-08 | $4.03M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-03-31 | $688.00K 10-Q · filed 2012-05-10 | $1.68M derived: sum of 2 quarters · filed 2012-05-10 | $3.35M derived: sum of 3 quarters · filed 2012-11-01 | $4.74M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-12-31 | $992.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $2.66M derived: sum of 2 quarters · filed 2012-11-01 | $4.05M derived: sum of 3 quarters · filed 2012-11-01 | $5.25M 10-K · filed 2012-03-09 |
| 2011-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $3.06M derived: sum of 2 quarters · filed 2012-11-01 | $4.26M 10-Q · filed 2012-11-01 | $5.67M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $2.59M 10-Q · filed 2012-08-08 | $4.00M derived: sum of 3 quarters · filed 2012-08-08 | $5.77M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | $1.20M 10-Q · filed 2012-05-10 | $2.61M derived: sum of 2 quarters · filed 2012-05-10 | $4.38M derived: sum of 3 quarters · filed 2012-05-10 | |
| 2010-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $3.18M derived: sum of 2 quarters · filed 2012-03-09 | $6.71M 10-K · filed 2012-03-09 | |
| 2010-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $5.29M 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $3.52M 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | $6.16M 10-K · filed 2012-03-09 |